Dyne Therapeutics Inc. (NASDAQ: DYN) is one of the 13 hot stocks to buy with the highest upside potential. As of February 13, ...

Del-desiran (also known as AOC1001) is an antibody-oligonucleotide conjugate comprised of a DMPK small interfering RNA (siRNA ...

The Muscular Dystrophy Association (MDA) announced its nationwide MDA Shamrocks campaign, uniting with retail partners across the country to make a meaningful impact for families living with rare ...

PBGENE-DMD has received Investigational New Drug clearance from the U.S. Food and Drug Administration (FDA) enabling initiation of clinical trial site activation. PBGENE-DMD was previously granted FDA ...

The Muscular Dystrophy Association (MDA) today announced Łukasz Sznajder, PhD, MSc, Assistant Professor, Department of Chemistry and Biochemistry, University of Nevada, Las Vegas (UNLV), as the first ...

A preclinical study led by the Germans Trias i Pujol Research Institute (IGTP), in collaboration with the Institut de ...

In the book “Good Enough: 40ish Devotionals for a Life of Imperfection,” authors Kate Bowler and Jessica Richie write, “Blessed are you who are buried. You who feel stuck in the depths of grief and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The search for a treatment for ...

There is no cure for DMD, but treatments can slow the progression of the disease and help improve quality of life. Duchenne muscular dystrophy (DMD) is a chronic condition that causes a gradual loss ...

Pictured (left to right): Jody Plonski, Market 32 and Price Chopper SVP of Operations; Blaine Bringhurst, Market 32 and Price Chopper President; Michele McKeever, Market 32 and Price Chopper Director ...

Please see Important Safety Information below and the full Prescribing Information. CONCORD, Mass., Aug. 25, 2025 /PRNewswire/ -- ITF Therapeutics LLC, the U.S. affiliate of Italfarmaco, today ...